ViviCells International
VCII · OTC
About VCII
- Employees
- 0
- Headquarters
- St. Petersburg, Florida
- Listed
- Jun 21, 2001
- Sector
- Health Care
- Industry
- Health Care Providers & Services
VCII key statistics
- Market cap
- 114
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 5.07K
- Volume
- 107
- Open price
- $0.00
- High today
- $0.00
- Low today
- $0.00
- 52 Week high
- $0.0001
- 52 Week low
- $0.00
ViviCells International (VCII) at a glance
ViviCells International (VCII) last traded at $0.00, with a market cap of 114.
Volume so far is 107 shares, below the average of 5.07K shares a day.
Over the past year ViviCells International has ranged from $0.00 to $0.0001, and now sits 0% of the way up that range.
Similar companies
Companies in the same industry as ViviCells International
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- SDSTStardust Power$0.02−23.66%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- NWGLCL Workshop Group$0.1522+27.90%
- AHTAshford Hospitality Trust$1.79−2.72%
- DKIDarkiris$0.0479−6.08%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- SPCXSpace Exploration Technologies$147.79−0.11%
- SOXLDirexion Shares ETF Trust$97.55−1.12%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.